ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis
- Conditions
- Tuberculosis
- First Posted Date
- 2018-02-06
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT03423550
- Locations
- 🇰🇷
Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Distribution of Helicobacter Pylori After Gastrectomy
- Conditions
- Helicobacter Pylori Infections
- Interventions
- Diagnostic Test: Endoscopic biopsy
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT03419936
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Preemptive Analgesic Effects of Popliteal Sciatic Nerve Block in Patients With Bilateral Hallux Valgus Surgery
Not Applicable
- Conditions
- Acute PainPreemptive Peripheral Nerve BlockPain, Postoperative
- Interventions
- Drug: Ultrasound guided popliteal sciatic nerve block with 0.2% ropivcaine
- First Posted Date
- 2018-01-30
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT03414593
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Preemptive Analgesic Effects of Rectus Sheath Block in Laparoscopic Cholecystectomy Patients
Not Applicable
Completed
- Conditions
- Preemptive Peripheral Nerve BlockPain, PostoperativeAcute Pain
- Interventions
- Drug: Ultrasound guided Rectus sheath blockDrug: Intercostal nerve block
- First Posted Date
- 2018-01-29
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT03413280
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Abbreviated 3 Cycles of Rituximab Plus CHOP(Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients With Completely Excised LocalizedGastrointestinal CD(Cluster of Differentiation Antigen)20(+) Diffuse Large B-cell Lymphoma
Phase 2
- Conditions
- Diffuse Large B-cell Lymphoma
- Interventions
- Drug: Abb-R-CHOP
- First Posted Date
- 2018-01-16
- Last Posted Date
- 2018-01-16
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT03399747
TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2021-04-27
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 63
- Registration Number
- NCT03394118
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer
Phase 2
Completed
- Conditions
- Pleural Effusion, MalignantNon-small Cell Carcinoma
- Interventions
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2019-03-08
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT03394105
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™
Not Applicable
Completed
- Conditions
- Urinary Bladder NeoplasmsProstatic Neoplasms
- Interventions
- Other: PEEP
- First Posted Date
- 2018-01-04
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 68
- Registration Number
- NCT03390127
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
The Effect of Remote Ischemic Preconditioning in Living Donor Hepatectomy
Not Applicable
Completed
- Conditions
- Liver TransplantationIschemia Reperfusion InjuryTissue Donors
- Interventions
- Procedure: remote ischemic preconditioning
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2019-08-19
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 160
- Registration Number
- NCT03386435
- Locations
- 🇰🇷
Asan medical center, Seoul, Songpa-gu, Korea, Republic of
A Phase II Trial of Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy for Refractory or Relapsed Diffuse Large B Cell Lymphoma
Phase 2
- Conditions
- Diffuse Large B Cell Lymphoma
- Interventions
- Drug: Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy
- First Posted Date
- 2017-12-26
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT03383406
© Copyright 2025. All Rights Reserved by MedPath